Unicycive Therapeutics's three largest insider shareholders as of August 04, 2026 are Gaurav Aggarwal (Director, 3.47Mn shares), Shalabh K. Gupta (Ceo, 2.53Mn shares), Gaurav Aggarwal (Director, 1.79Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Gaurav Aggarwal | - | 0 | 3,470,152 | 13 Jul, 2023 |
| Pramod Gupta | Evp, Pharmaceuticals And Bd | 41,845 | 0 | 13 Jul, 2023 |
| Brigitte Schiller | - | 26,738 | 0 | 30 Aug, 2022 |
| Shalabh K. Gupta | Ceo | 2,527,449 | 0 | 13 Jul, 2023 |
| Douglas Jermasek | Evp Of Corporate Strategy | 175,012 | 0 | 13 Jul, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 25 Aug, 2025 | Gaurav Aggarwal | Common Stock | A | 652,900 | - | 1,789,915 | I | C |
| 25 Aug, 2025 | Gaurav Aggarwal | Series A-2 Prime Preferred Stock | D | 3,199 | $1,000.00 | 0 | I | D |
| 28 Jul, 2025 | John Townsend | Stock Options | A | 10,000 | $0.00 | 101,557 | D | A |
| 28 Jul, 2025 | Gaurav Aggarwal | Stock Options | A | 21,200 | $0.00 | 39,200 | D | A |
| 28 Jul, 2025 | Douglas Jermasek | Stock Options | A | 10,000 | $0.00 | 215,500 | D | A |
| 28 Jul, 2025 | Sandeep Laumas | Stock Options | A | 21,200 | $0.00 | 41,286 | D | A |
| 28 Jul, 2025 | Pramod Gupta | Stock Options | A | 90,000 | $0.00 | 301,986 | D | A |
| 28 Jul, 2025 | Sara Kenkare-Mitra | Stock Options | A | 21,200 | $0.00 | 39,200 | D | A |
| 28 Jul, 2025 | Shalabh K. Gupta | Stock Options | A | 325,000 | $0.00 | 968,951 | D | A |
| 18 Feb, 2025 | Gaurav Aggarwal | Common Stock | A | 1,400,000 | - | 11,370,152 | I | C |
| 18 Feb, 2025 | Gaurav Aggarwal | Series A-2 Prime Preferred Stock | D | 686 | $1,000.00 | 3,119 | I | D |
| 09 Oct, 2024 | Gaurav Aggarwal | Common Stock | A | 5,500,000 | - | 9,970,152 | I | C |
| 09 Oct, 2024 | Gaurav Aggarwal | Series A-2 Prime Preferred Stock | D | 2,695 | $1,000.00 | 3,885 | I | D |
| 12 Aug, 2024 | Pramod Gupta | Stock Options | A | 81,750 | $0.00 | 2,119,862 | D | A |
| 12 Aug, 2024 | Douglas Jermasek | Stock Options | A | 81,750 | $0.00 | 2,055,000 | D | A |
| 12 Aug, 2024 | John Townsend | Stock Options | A | 40,256 | $0.00 | 915,565 | D | A |
| 12 Aug, 2024 | Shalabh K. Gupta | Stock Options | A | 232,868 | $0.00 | 6,439,505 | D | A |
| 15 Apr, 2024 | Shalabh K. Gupta | Stock Options | A | 1,319,583 | $0.00 | 6,206,637 | D | A |
| 15 Apr, 2024 | Douglas Jermasek | Stock Options | A | 463,250 | $0.00 | 1,973,250 | D | A |
| 15 Apr, 2024 | Pramod Gupta | Stock Options | A | 463,250 | $0.00 | 2,038,112 | D | A |